Inventor · disambiguated record
Andre Lescarbeau
Also filed as: LESCARBEAU ANDRE · LESCARBEAU ANDRÉ
48 granted patents·10 pending applications·582 citations·filing 2003–2024
98Inventor score
Files withINFINITY PHARMACEUTICALS INC26RELAY THERAPEUTICS INC13CASTRO ALFREDO C4EISAI R&D MAN CO LTD4AUSTAD BRIAN2
Top patents by PatentIndex Score
58 records- 0199US7812164B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·84 cites·2 claims
- 0297US8785470B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jul 22, 2014·41 cites·24 claims
- 0396US10934302B1SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·44 cites·7 claims
- 0496US9359365B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jun 7, 2016·24 cites·24 claims
- 0596US9238672B2Methods for stereoselective reductionINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jan 19, 2016·14 cites·24 claims
- 0696US8969363B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Mar 3, 2015·44 cites·56 claims
- 0796US8940742B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Jan 27, 2015·35 cites·48 claims
- 0895US10406139B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·8 cites·5 claims
- 0995US9115141B2Substituted isoquinolinones and methods of treatment thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 25, 2015·27 cites·49 claims
- 1094US9775844B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Oct 3, 2017·13 cites·48 claims
- 1194US9492435B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 15, 2016·13 cites·15 claims
- 1294US9255108B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·21 cites·45 claims
- 1394US8785635B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Jul 22, 2014·16 cites·38 claims
- 1494US8716479B2Methods for stereoselective reductionAUSTAD BRIAN C·Filed 2008·Granted May 6, 2014·19 cites·16 claims
- 1594US8669365B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Mar 11, 2014·21 cites·25 claims
- 1694US7964590B2Cyclopamine lactam analogs and methods of use thereofINFINITY DISCOVERY INC·Filed 2008·Granted Jun 21, 2011·29 cites·19 claims
- 1793US9056877B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jun 16, 2015·25 cites·32 claims
- 1893US8293760B2Cyclopamine lactam analogs and methods of use thereofCASTRO ALFREDO C·Filed 2011·Granted Oct 23, 2012·19 cites·36 claims
- 1992US10329299B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·7 cites·26 claims
- 2091US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 2191US11541059B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·2 cites·11 claims
- 2290US11007181B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·1 cites·2 claims
- 2390US9951083B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·4 cites·19 claims
- 2490US8431566B2Cyclopamine lactam analogs and methods of use thereofCASTRO ALFREDO·Filed 2011·Granted Apr 30, 2013·19 cites·23 claims
- 2588US12219327B2Substituted isoindolines as PI3K-alpha inhibitorsRELAY THERAPEUTICS INC·Filed 2023·Granted Feb 4, 2025·1 cites·6 claims
- 2688US11247995B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Feb 15, 2022·2 cites·44 claims
- 2788US7683200B2Compounds for preparing immunological adjuvantEISAI R&D MAN CO LTD·Filed 2006·Granted Mar 23, 2010·11 cites·11 claims
- 2887US9828377B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·4 cites·43 claims
- 2985US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 3082US12384792B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameTWELVE THERAPEUTICS INC·Filed 2024·Granted Aug 12, 2025·0 cites·9 claims
- 3182US11890281B2SHP2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·1 cites·27 claims
- 3282US2025171453A1Heterocyclic compounds and uses thereofTWELVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3381US11939333B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2022·Granted Mar 26, 2024·0 cites·18 claims
- 3481US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 3581US10160761B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 25, 2018·2 cites·43 claims
- 3681US9605003B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Mar 28, 2017·3 cites·39 claims
- 3779US9751888B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Sep 5, 2017·2 cites·19 claims
- 3879US8198474B2Compounds for preparing immunological adjuvantFANG FRANCIS G·Filed 2010·Granted Jun 12, 2012·4 cites·20 claims
- 3978US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 4078US2024050437A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4177US9546180B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·2 cites·29 claims
- 4276US12152032B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2021·Granted Nov 26, 2024·0 cites·17 claims
- 4376US7314936B2Deazapurines and uses thereofEISAI CO LTD·Filed 2003·Granted Jan 1, 2008·8 cites·34 claims
- 4475US8519170B2Compounds for preparing immunological adjuvantFANG FRANCIS G·Filed 2012·Granted Aug 27, 2013·2 cites·6 claims
- 4574US12152034B2FGFR inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·1 cites·19 claims
- 4671US2024122925A1Shp2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4768US2019367521A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4865US8962857B2Compounds for preparing immunological adjuvantEISAI R&D MAN CO LTD·Filed 2014·Granted Feb 24, 2015·0 cites·3 claims
- 4965US2022315586A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 5063US8754236B2Compounds for preparing immunological adjuvantEISAI R&D MAN CO LTD·Filed 2013·Granted Jun 17, 2014·0 cites·2 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andre Lescarbeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →